← Leaderboards
Jonathan Abraham
Brigham And Women'S Hospital
$3,836,355
Attributed
$4,069,417
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $752.5K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,069,417 · 3
By mechanism
DP5$2,138,750 · 1
R01$1,464,542 · 1
R21$466,125 · 1
Top collaborators
- Donald M Coen2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Peter T Lansbury$7,464,017
Others in their field
Top investigators on “Virus Diseases”
- Barton F Haynes · Duke University$305,832,186
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Lawrence Corey · Fred Hutchinson Cancer Center$271,990,515
- Richard Webby · St. Jude Children'S Research Hospital$264,105,723
- David Heimbrook · Leidos Biomedical Research, Inc.$262,417,885
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$252,117,999
Research focus
Virus DiseasesVirusCryoelectron MicroscopyBindingVirus ReplicationVaccinesDesignComplexStructureViralNovel TherapeuticsX-Ray CrystallographyCellsAntiviral AgentsInfectionMolecularCase Fatality RatesBrainPreventCollaborationsComplementAntibody ResponseBloodAntibodies
Grant awards (9)
Structural and functional studies of alphavirus receptors$712,062
R01 · FY2025 · AI · contact PI
Structural and functional studies of alphavirus receptors$752,480
R01 · FY2024 · AI · contact PI
Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes$423,750
DP5 · FY2020 · OD · contact PI
Structural studies of herpesvirus DNA polymerases$254,250
R21 · FY2020 · AI
Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes$423,750
DP5 · FY2019 · OD · contact PI
Structural studies of herpesvirus DNA polymerases$211,875
R21 · FY2019 · AI
Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes$423,750
DP5 · FY2018 · OD · contact PI
Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes$423,750
DP5 · FY2017 · OD · contact PI
Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes$443,750
DP5 · FY2016 · OD · contact PI